Virtus Fund Advisers’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-1,825
Closed -$191K 2643
2014
Q2
$191K Buy
+1,825
New +$191K ﹤0.01% 988